About Blue Cross Laboratories Private Limited
Data last updated:
Blue Cross Laboratories Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 July 1980 and has been in existence for over 46 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1980PTC022825. Its GSTIN is 27AAACB1549G1ZX (Maharashtra). The company holds 25 GST registrations, of which 18 are active.
The company has an authorised share capital of ₹100 Cr and a paid-up capital of ₹64.8 Cr. It was formerly known as Blue Cross Laboratories Limited. It is led by directors including Bhalchandra Barve Govind (Managing Director) and Manoj Nihchal Israni (Managing Director).
Its last annual general meeting (AGM) was held on 08 May 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Peninsula Chambers Peninsula Corporate Park Ganpatrao Kadam Marg Lower Parel, Mumbai, Maharashtra, India – 400013.
As per the financials filed for FY 2026, the company reported a revenue of ₹1,017.99 Cr. For the same year it recorded a net profit of ₹232.38 Cr (net margin 22.8%) and EBITDA of ₹325.17 Cr (EBITDA margin 31.9%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 8% over five years.
The company has about 2,801 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Blue Cross Laboratories. As per MCA filings, the company has satisfied charges of ₹10.35 Cr on record. Court records list 104 cases involving the company, including 86 filed by the company and 18 filed against it; 29 cases are pending. The company has 9 deals on record (9 secondary share transfers); the latest was in March 2014. Its 9 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 5 smaller; the largest is Zuventus Healthcare Limited with revenue of ₹1,117.95 Cr. The company has 2 MSME Form 1 returns on record for the period ending Mar 2020, listing 17 overdue payments to 12 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website bluecrosslabs.com.
Company details
CIN history
Blue Cross Laboratories has one previous CIN (Corporate Identification Number): U24230MH1980PLC022825. The current CIN is U24230MH1980PTC022825, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230MH1980PTC022825 | Current |
| U24230MH1980PLC022825 | Previous |
Contact details
Blue Cross Laboratories Private Limited's registered office is in Mumbai, Maharashtra. Its website is bluecrosslabs.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPeninsula Chambers Peninsula Corporate Park Ganpatrao Kadam Marg Lower Parel, Mumbai, Maharashtra, India – 400013
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Blue Cross Laboratories Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Blue Cross Laboratories operates one associated brand: Blue Cross Laboratories. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Production of affordable pharmaceutical medicines for domestic and international markets. | bluecrosslabs.com |
Business activity
The main business activity of Blue Cross Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Blue Cross Laboratories Private Limited, buy the company report.
Financials of Blue Cross Laboratories Private Limited
FY 2025 filings availableBlue Cross Laboratories Private Limited reported revenue of ₹1,017.99 Cr for FY 2026.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 8% over five years. EBITDA fell 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹325.17 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹232.38 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 31.9% | ||||
| Net Profit Margin | 22.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Blue Cross Laboratories Private Limited, buy the company report.
Board of directors of Blue Cross Laboratories Private Limited
Blue Cross Laboratories has 8 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ketki Raj Wadhawa Also directs: Niko Management Services Private Limited | Director | 15 Apr 2020 | 6 Years 6 Months | Current |
| Bhalchandra Barve Govind Also directs: Council for Fair Business Practices | Managing Director | 18 May 1998 | 28 Years 5 Months | Current |
| Rohit Jayaramdas Patel Also directs: Keyur Trading Company LLP, VFC Industries Private Limited, JMP Trading and Properties Private Limited and 1 more | Director | 05 Dec 2007 | 18 Years 10 Months | Current |
| Rajendra Yeshwant Padhye Also directs: Nihchal Israni Foundation | Director | 17 Nov 2010 | 15 Years 11 Months | Current |
| Ashish Mangesh Shirsat | Whole-Time Director | 01 Sep 2006 | 20 Years 1 Months | Current |
| Manoj Nihchal Israni | Managing Director | 21 Jun 2018 | 8 Years 4 Months | Current |
Peer comparison
Blue Cross Laboratories Private Limited is compared with the 9 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Zuventus Healthcare Limited | ₹1,117.95 Cr (FY 2025) | 4.0% | Pune, Maharashtra, India | |||
| Medley Pharmaceuticals Limited | ₹1,114.92 Cr (FY 2025) | 8.0% | Mumbai, Maharashtra, India | |||
| Troikaa Pharmaceuticals Limited | ₹1,088.44 Cr (FY 2025) | 12.0% | Ahmedabad, Gujarat, India | |||
| Tenshi Pharmaceuticals Private Limited | ₹1,071.06 Cr (FY 2024) | 98.0% | Bangalore, Karnataka, India | |||
| Blue Cross Laboratories Private Limitedthis company | ₹1,017.99 Cr (FY 2026) | ₹232.38 Cr | 22.8% | 2,801 | Mumbai, Maharashtra, India | |
| Win-Medicare Private Limited | ₹1,012.12 Cr (FY 2025) | 7.0% | New Delhi, Delhi, India | |||
| Umedica Laboratories Private Limited | ₹993.72 Cr (FY 2025) | 21.0% | Pardi, Gujarat, India | |||
| Franco-Indian Pharmaceuticals Private Limited | ₹988.53 Cr (FY 2024) | 0.0% | Mumbai, Maharashtra, India | |||
| Meyer Organics Private Limited | ₹984.18 Cr (FY 2025) | 12.0% | Thane, Maharashtra, India | |||
| Biocon Pharma Limited | ₹982.5 Cr (FY 2025) | 11.0% | Bangalore, Karnataka, India |
To see the full peer comparison of Blue Cross Laboratories Private Limited, buy the company report.
Auditor
Blue Cross Laboratories Private Limited is audited by B. S. MEHTA & CO. for the financial year 2025.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| B. S. MEHTA & CO. | FY 2025 | 106190W |
Shareholding
The shareholding of Blue Cross Laboratories Private Limited is on record for 5 financial years, the latest being FY 2025, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Blue Cross Laboratories Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 07 Jan 1999 | 80042579 | Central Bank of India (Lead Bank ) | ₹10.35 Cr | Satisfied |
To see the full charge records of Blue Cross Laboratories Private Limited, buy the company report.
Total charge records: 1 View all charges
Deals & funding
Blue Cross Laboratories Private Limited has 9 deals on record (9 secondary share transfers); the latest was in March 2014.
Deals on record (5 of 9)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2014 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: Niko Management Services Private Limited |
| Mar 2014 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: NH Israni HUF |
| Mar 2013 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: NH Israni HUF |
| Mar 2012 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
| Mar 2011 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
To see the full deal history of Blue Cross Laboratories Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Blue Cross Laboratories Private Limited has 104 court cases on record: 86 filed by Blue Cross Laboratories, 18 filed against it. 29 cases are pending and 75 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 82 | 5 | 23 |
| District courts | 21 | 12 | 6 |
| Supreme Court | 1 | 1 | 0 |
Cases on record (5 of 104)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (LPETN) | Filed by the company against BMH Pharma | Pending |
| Bombay High Court | Interim or miscellaneous application | Filed by the company against Habitare Pharma Private Limited and 1 other | Pending |
| High Court | Interim or miscellaneous application | Filed by the company against Jineka Healthcare Private Limited and 1 other | Pending |
| High Court | Court case (COMIP) | Filed by the company against Habitare Pharma Private Limited and 1 other | Pending |
| High Court, MAHARASHTRA | Court case (CRR) | Filed by the company against Jineka Healthcare Private Limited | Pending |
To see the full case history of Blue Cross Laboratories Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Blue Cross Laboratories Private Limited has 2 MSME Form 1 returns on record for the period ending Mar 2020, listing 17 overdue payments to 12 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 12)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Samarth Turnkey Solutions Private Limited | |||
| Sigma Air Filters | |||
| an individual supplier | |||
| Lab World Goa | |||
| an individual supplier |
To see the full MSME payment records of Blue Cross Laboratories Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Blue Cross Laboratories Private Limited has a workforce of 2,801 employees on its EPFO records as of Jan 07, 2026, across 2 active EPFO establishments.
GST
Blue Cross Laboratories has 25 GST registrations: 18 active and 7 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACB1549G1ZX | Maharashtra | Active | 01 Jul 2017 |
| 27AAACB1549G2ZW | Maharashtra | Active | 10 Jul 2017 |
| 08AAACB1549G1ZX | Rajasthan | Active | 01 Jul 2017 |
| 09AAACB1549G1ZV | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Blue Cross Laboratories Private Limited, buy the company report.
Recent activity
Blue Cross Laboratories Private Limited has 18 board changes on record since 1980: 9 appointments and 9 cessations. The latest: Anup Kumar Romesh Burman ceased to be Additional Director on 29 Jun 2020.
12 earlier events are in the company report.
Frequently asked questions
Blue Cross Laboratories is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 July 1980 (46+ years old) and is registered under CIN U24230MH1980PTC022825.
Blue Cross Laboratories has 8 current directors:
- Bhalchandra Barve Govind - Managing Director
- Manoj Nihchal Israni - Managing Director
- Ashish Mangesh Shirsat - Whole-Time Director
- Ketki Raj Wadhawa - Director
- Rohit Jayaramdas Patel - Director
- Rajendra Yeshwant Padhye - Director
- Satyanarain Rameshwardas Agarwala - Director
- Nihchal Israni - Director
The latest financial statements of Blue Cross Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 08 May 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Blue Cross Laboratories is 27AAACB1549G1ZX, registered in Maharashtra. The company has 25 GST registrations in all, of which 18 are active and 7 are cancelled or inactive. Other active GSTINs include 27AAACB1549G2ZW (Maharashtra), 08AAACB1549G1ZX (Rajasthan), 09AAACB1549G1ZV (Uttar Pradesh).
The CIN (Corporate Identification Number) of Blue Cross Laboratories is U24230MH1980PTC022825. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Blue Cross Laboratories has 104 court cases on record: 86 filed by the company and 18 filed against it. 29 are pending. Most are in the high courts.
Blue Cross Laboratories was incorporated on 09 July 1980, making it 46+ years old. It is registered with the Registrar of Companies, Mumbai.
Blue Cross Laboratories has 9 deals on record (9 secondary share transfers); the latest was in March 2014.
The peers of Blue Cross Laboratories by revenue are Zuventus Healthcare Limited, Medley Pharmaceuticals Limited, Troikaa Pharmaceuticals Limited, Tenshi Pharmaceuticals Private Limited, Win-Medicare Private Limited and 4 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Anup Kumar Romesh Burman ceased to be Additional Director on 29 Jun 2020. Ketki Raj Wadhawa ceased to be Additional Director on 29 Jun 2020. Ketki Raj Wadhawa was appointed as Director on 15 Apr 2020. Blue Cross Laboratories has 18 board changes on record in total.
Blue Cross Laboratories has 2 MSME Form 1 returns on record for the period ending Mar 2020, listing 17 overdue payments to 12 micro and small suppliers. The latest return was filed on 30 Sep 2020.
Blue Cross Laboratories can be reached through the website bluecrosslabs.com. Its registered office is in Mumbai, Maharashtra, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
